Nova Mentis Life Stock Fundamentals
| NMLSF Stock | USD 0.02 0.0008 3.69% |
Nova Mentis Life fundamentals help investors to digest information that contributes to Nova Mentis' financial success or failures. It also enables traders to predict the movement of Nova Pink Sheet. The fundamental analysis module provides a way to measure Nova Mentis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Mentis pink sheet.
Nova |
Nova Mentis Life Company Return On Equity Analysis
Nova Mentis' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nova Mentis Return On Equity | -0.89 |
Most of Nova Mentis' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Mentis Life is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nova Mentis Life has a Return On Equity of -0.8948. This is 96.27% lower than that of the Healthcare sector and 97.55% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 188.65% higher than that of the company.
Nova Mentis Life Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nova Mentis's current stock value. Our valuation model uses many indicators to compare Nova Mentis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nova Mentis competition to find correlations between indicators driving Nova Mentis's intrinsic value. More Info.Nova Mentis Life is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nova Mentis' earnings, one of the primary drivers of an investment's value.Nova Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Mentis' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nova Mentis could also be used in its relative valuation, which is a method of valuing Nova Mentis by comparing valuation metrics of similar companies.Nova Mentis is rated below average in return on equity category among its peers.
Nova Fundamentals
| Return On Equity | -0.89 | |||
| Return On Asset | -0.52 | |||
| Current Valuation | 5.46 M | |||
| Shares Outstanding | 143.47 M | |||
| Shares Owned By Insiders | 11.73 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Book | 7.68 X | |||
| Price To Sales | 5,731 X | |||
| Gross Profit | (5.44 K) | |||
| EBITDA | (2.93 M) | |||
| Net Income | (2.68 M) | |||
| Cash And Equivalents | 634.36 K | |||
| Current Ratio | 4.50 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.95 M) | |||
| Earnings Per Share | (0.02) X | |||
| Beta | 0.86 | |||
| Market Capitalization | 7.7 M | |||
| Total Asset | 881.16 K | |||
| Z Score | -9.9 | |||
| Net Asset | 881.16 K |
About Nova Mentis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Mentis Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Mentis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Mentis Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. Nova Mentis is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Nova Pink Sheet
Nova Mentis financial ratios help investors to determine whether Nova Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Mentis security.